Selected for a Total of 2.52 Billion KRW Research and Development Support Project by 2025
Aiming for US Clinical Trials and FDA Approval

Medical AI specialist company Huron announced on the 7th that its automatic classification AI solution for emergency stroke patients has been selected for support under the ‘Pan-Government Full-Cycle Medical Device R&D Project’ worth a total of 2.52 billion KRW by 2025. This support project aims to develop products securing global competitiveness, strengthen medical device commercialization capabilities, and lead the 4th Industrial Revolution and future medical environments.

Huron Selected for Pan-Ministerial Full-Cycle Medical Device R&D Support Project View original image

Through this support project, Huron aims to conduct clinical trials in the United States and obtain FDA approval for its automatic classification AI solutions for emergency stroke patients based on non-contrast computed tomography (CT), as well as for the automatic classification AI solution for large vessel occlusion using angiographic CT. Based on this, the company plans to actively enter the global market. Huron’s stroke AI solution prioritizes patients requiring emergency treatment, assisting medical staff in making rapid decisions to provide fast and appropriate medical services to stroke patients.



Shin Dong-hoon, CEO of Huron, said, “Through this R&D project, we have gained the momentum to expand not only the currently commercialized non-contrast CT-based stroke solution but also solutions using angiographic CT to advance into the U.S. market.” He added, “We will successfully carry out this project to strengthen Huron’s technological capabilities and global market competitiveness.”


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing